Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 4/20 | 1.00 |
| ▸ | CSNK2B | P67870 | 4/20 | 1.00 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 0.76 |
| ▸ | TP53 | P04637 | 6/20 | 0.76 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 3/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | CASP1 | P29466 | 2/20 | 0.73 |
| ▸ | CASP7 | P55210 | 2/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | MAOB | P27338 | 1/20 | 0.65 |
| ▸ | ACHE | P22303 | 2/20 | 0.65 |
| ▸ | BACE1 | P56817 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4648920 | 1.00 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL4650608 | 0.91 | CSNK2A2 (0.82) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL17786466 | 0.86 | CSNK2A2 (0.75) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL12941170 | 0.86 | CSNK2A2 (0.75) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL5043660 | 0.86 | CSNK2A2 (0.75) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL7124716 | 0.85 | CSNK2A2 (0.74) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL30667444 | 0.85 | MAPT (1.00) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL5138212 | 0.85 | MAPT (1.00) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL30807197 | 0.84 | CYP3A4 (0.87) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 | |
| SCHEMBL12590664 | 0.84 | MAPT (0.84) | CSNK2A2CSNK2BCSNK2A1MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368629-A1 | FLAVONOID COMPOUNDS AND METHODS AND MATERIALS FOR USING FLAVONOID COMPOUNDS TO TREAT FIBROTIC CONDITIONS | MAYO FOUND MEDICAL EDUCATION & RES (US) | 2025-12-04 | — | — | US | disclosed |
| CN-119365193-A | Flavonoid compounds and methods and materials for treating fibrotic disorders using flavonoid compounds | 梅约医学教育与研究基金会 | 2025-01-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368629-A1 | FLAVONOID COMPOUNDS AND METHODS AND MATERIALS FOR USING FLAVONOID COMPOUNDS TO TREAT FIBROTIC CONDITIONS | FABP1, FN1, MMP1 | CSNK2A2 4537/4885CSNK2B 4384/4885CSNK2A1 4564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.